Michael McDonald

Ask VT AI
View News Summary
  • Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.
  • Musk and Bezos, two tech titans, reignite their rivalry over election claims, highlighting their competitive history in various sectors.
  • Gensler's resignation as SEC Chair signals a potential pro-crypto shift under Trump's administration, raising speculation about his successor and the future of crypto regulation.
20 hours
USA flag

Politics in the United States

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Novartis raises mid-term sales guidance, citing strong drug performance and promising pipeline, but analysts express concerns about sustaining growth beyond 2029.
  • Musk and Bezos, two tech titans, reignite their rivalry over election claims, highlighting their competitive history in various sectors.
  • Gensler's resignation as SEC Chair signals a potential pro-crypto shift under Trump's administration, raising speculation about his successor and the future of crypto regulation.
20 hours
USA flag

Politics in the United States

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Michael McDonald